Eli Lilly and Company

◌ Pending Review

💊 Healthcare / PharmaceuticalsUSBelow expectations

~43,000 employees~$45B revenue4.2Mt CO₂e totalRanked #146 of 324Website ↗

Eli Lilly and Company is a healthcare / pharmaceuticals company headquartered in US with total reported emissions of 4.2Mt CO₂e per year. Based on our 10-question rubric, Eli Lilly and Company scores 39/100 — rated as below expectations on sustainability for a company of its size and profile.

SINK Score Breakdown

How we calculated Eli Lilly and Company's score using our formula: (0.3 × Base + 0.7 × Performance) × Scale Penalty

Base Impact

Healthcare / Pharmaceuticals industry ceiling

Performance

48/100

10 questions scored below

Scale Penalty

0.82x

emissions volume multiplier

SINK Score

(0.3 × 45 + 0.7 × 48) × 0.82 = 39

Emissions Breakdown

Scope 1

192Kt

Direct emissions

Scope 2

258Kt

Energy (purchased)

Scope 3

3.7Mt

Value chain

Total

4.2Mt

CO₂e per year

10-Question Rubric Breakdown

Click any question to see the reasoning, sources and community challenges.

7/10

Carbon Footprint — Operations

6/10

Carbon Footprint — Supply Chain

4/10

Emissions Trajectory

6/10

Energy Source

4/10

Nature & Biodiversity Impact

6/10

Resource Use & Waste

5/10

Water Impact

3/10

Targets & Commitments

6/10

Transparency & Accountability

Q10

1/10

Controversies & Red Flags

Community Verification

0 verifications · 0 challenges · Scored using SINK editorial review

Last scored: 4 Apr 2026

Think this score is wrong?

Challenge any question above with evidence. All challenges are published publicly.

Read methodology →